AU2002220416A1 - Oncolytic virus - Google Patents

Oncolytic virus

Info

Publication number: AU2002220416A1
Authority: AU; Australia
Prior art keywords: oncolytic virus; oncolytic; virus
Prior art date: 2000-12-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002220416A

Inventor

John Cameron Bell

Earl Garnet Brown

Jean Lutamyo Mbisa

David Francis Stodjl

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Ottawa

Original Assignee

University of Ottawa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-01

Filing date

2001-11-30

Publication date

2002-06-11

2001-11-30 Application filed by University of Ottawa filed Critical University of Ottawa

2002-06-11 Publication of AU2002220416A1 publication Critical patent/AU2002220416A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
- C12N2720/12232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Biochemistry (AREA)
Mycology (AREA)
Biotechnology (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2002220416A 2000-12-01 2001-11-30 Oncolytic virus Abandoned AU2002220416A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US25013100P	2000-12-01	2000-12-01
US60/250,131		2000-12-01
US32701601P	2001-10-05	2001-10-05
US60/327,016		2001-10-05
PCT/CA2001/001703 WO2002043647A2 (en)	2000-12-01	2001-11-30	Oncolytic virus

Publications (1)

Publication Number	Publication Date
AU2002220416A1 true AU2002220416A1 (en)	2002-06-11

Family

ID=26940619

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2002220416A Abandoned AU2002220416A1 (en)	2000-12-01	2001-11-30	Oncolytic virus
AU2002243257A Abandoned AU2002243257A1 (en)	2000-12-01	2001-12-03	Oncolytic virus

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU2002243257A Abandoned AU2002243257A1 (en)	2000-12-01	2001-12-03	Oncolytic virus

Country Status (5)

Country	Link
EP (1)	EP1339736A2 (en)
JP (1)	JP2004519431A (en)
AU (2)	AU2002220416A1 (en)
CA (1)	CA2430495A1 (en)
WO (2)	WO2002043647A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPQ425699A0 (en)	1999-11-25	1999-12-23	University Of Newcastle Research Associates Limited, The	A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
AU2002953436A0 (en)	2002-12-18	2003-01-09	The University Of Newcastle Research Associates Limited	A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
WO2005111200A1 (en) *	2004-05-17	2005-11-24	Universite De Montreal	Novel strains of reoviruses and methods of uses thereof
US10668119B2 (en)	2005-08-01	2020-06-02	Virocure, Inc.	Attenuated reovirus
CA2617600A1 (en)	2005-08-01	2007-09-07	University Technologies International, Inc.	Attenuated reovirus
EP2132315B1 (en)	2007-03-12	2015-07-15	Oncolytics Biotech Inc.	Reoviruses having modified sequences
US10369171B2 (en)	2007-03-13	2019-08-06	Virocure, Inc.	Attenuated reoviruses for selection of cell populations
WO2019237063A1 (en) *	2018-06-07	2019-12-12	Emory University	Modified reoviruses, particles, and uses in treating proliferative disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6110461A (en) *	1997-08-13	2000-08-29	Oncolytics Biotech Inc.	Reovirus for the treatment of neoplasia
US6136307A (en) *	1997-08-13	2000-10-24	Oncolytics Biotech Inc.	Reovirus for the treatment of cellular proliferative disorders
WO1999045783A1 (en) *	1998-03-12	1999-09-16	The Trustees Of The University Of Pennsylvania	Producer cells for replication selective viruses in the treatment of malignancy

2001
- 2001-11-30 CA CA002430495A patent/CA2430495A1/en not_active Abandoned
- 2001-11-30 WO PCT/CA2001/001703 patent/WO2002043647A2/en not_active Ceased
- 2001-11-30 EP EP01998300A patent/EP1339736A2/en not_active Ceased
- 2001-11-30 JP JP2002545626A patent/JP2004519431A/en active Pending
- 2001-11-30 AU AU2002220416A patent/AU2002220416A1/en not_active Abandoned
- 2001-12-03 WO PCT/US2001/045108 patent/WO2002050304A2/en not_active Ceased
- 2001-12-03 AU AU2002243257A patent/AU2002243257A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2002243257A1 (en)	2002-07-01
WO2002050304A3 (en)	2002-11-28
WO2002043647A2 (en)	2002-06-06
CA2430495A1 (en)	2002-06-06
WO2002050304A2 (en)	2002-06-27
EP1339736A2 (en)	2003-09-03
WO2002043647A3 (en)	2003-01-03
JP2004519431A (en)	2004-07-02

Publication	Publication Date	Title
AU2002210450A1 (en)	2002-03-13	Maintaining virus detection software
AU2002221749A1 (en)	2002-05-06	Synthetic viruses and uses thereof
AU6419701A (en)	2001-12-11	Electropancreatography
AU2001282528A1 (en)	2002-03-22	Compounds having anti-hepatitis c virus effect
AUPQ912000A0 (en)	2000-08-24	Improved virus like particles
AU2000267458A1 (en)	2001-10-15	Hypercomputer
AU2001239310A1 (en)	2001-10-03	Decahydro-isoquinolines
IL153879A0 (en)	2003-07-31	Modified virus
AU2001290931A1 (en)	2002-03-26	Ski-snowboard
AU2001285886A1 (en)	2002-03-22	2-guanidino-4-aryl-quinazoline
AU2002306709A1 (en)	2002-09-24	Oncolytic rna replicons
AU2001293852A1 (en)	2002-06-27	Sulfonylguanidine
AU2001240791A1 (en)	2001-09-24	Sequence
AU2001262689A1 (en)	2002-03-07	Oligopeptides
AU2002243257A1 (en)	2002-07-01	Oncolytic virus
GB0001475D0 (en)	2000-03-15	Virus strains
AUPR160400A0 (en)	2000-12-14	Plant virus promoter
AU2002224845A1 (en)	2002-05-21	Viral expression system
AU2002222139A1 (en)	2002-06-18	Hcv vaccines
AU2002354841A1 (en)	2003-03-03	Engineering oncolytic viruses
AU2691400A (en)	2000-09-14	Virus vector
HK1058475A (en)	2004-05-21	Oncolytic virus therapy
GB0002854D0 (en)	2000-03-29	Virus strains
HK1056833A (en)	2004-03-05	Hpv-specific short-mers
AU785203C (en)	2013-10-31	Zeroclick